Yıl: 2018 Cilt: 19 Sayı: 1 Sayfa Aralığı: 19 - 27 Metin Dili: İngilizce İndeks Tarihi: 22-08-2019

A Prospective Study of Bacteriological Etiology in Hospitalized Acute Exacerbation of COPD Patients: Relationship with Lung Function and Respiratory Failure

Öz:
OBJECTIVES: Bacterial infections are the major cause of acute exacerbation of COPD (AE-COPD). The relationship between lung func-tions and respiratory failure (arterial blood gas parameters) with the etiology of AE-COPD has not been clearly understood. We conductedthis study to determine the bacterial profile in AE-COPD and to identify the associated risk factors and drug sensitivity pattern.MATERIAL AND METHODS: Seventy-two patients hospitalized for AE-COPD were prospectively evaluated. Quantitative sputum culture,blood gas analysis, and drug sensitivity testing were performed at the time of admission, and pulmonary function testing was performed 6weeks after discharge as per standard guidelines.RESULTS: Bacterial pathogens were isolated in 34 (47.22%) cases. Pathogens isolated were Pseudomonas aeruginosa (38.23%), Klebsiellapneumoniae (29.41%), Staphylococcus aureus (23.53%), Streptococcus pneumoniae (5.88%), and Acinetobacter spp. (2.94%). Isola-tion of bacterial pathogen was observed in patients with advancing age (p=0.02), frequent exacerbations (p<0.001), systemic steroid use(p=0.005), and deranged lung function (p=0.02). Binary logistic regression analysis revealed that higher partial pressure of carbon dioxide(PaCO2) was independently associated with isolation of K. pneumoniae (p=0.025) and P. aeruginosa (p=0.001). Additional independentfactors that favor isolation of K. pneumoniae were age >55 years (p=0.017) and systemic steroid use (p=0.017). Antibiotic sensitivity test-ing showed that ciprofloxacin and piperacillin/tazobactum were effective in 27/34 (79.41%) of isolates followed by gentamycin in 26/34(76%).CONCLUSION: Hypercapnic respiratory failure is an independent risk factor for isolation of K. pneumoniae and P. aeruginosa in additionto advanced age and systemic steroid use. These findings may be an important adjunct in deciding the initial antibiotic therapy.
Anahtar Kelime:

Konular: Biyoteknoloji ve Uygulamalı Mikrobiyoloji
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • WHO | Burden of COPD [Internet]. WHO. [cited 2016 Feb 7]. Available from: http://www.who.int/respiratory/copd/burden/en/
  • Jindal SK, Aggarwal AN, Gupta D, et al. Indian study on epide- miology of asthma, respiratory symptoms and chronic bronchi- tis in adults (INSEARCH). Int J Tuberc Lung Dis 2012;16:1270-7. [CrossRef]
  • Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest 2000;117:398-401. [CrossRef]
  • Spencer S, Calverley PM, Burge PS, et al. Impact of preventing exacerbations on deterioration of health status in COPD. Eur Respir J 2004;23:698-702. [CrossRef]
  • Kessler R, Ståhl E, Vogelmeier C, et al. Patient understanding, detection, and experience of COPD exacerbations: an ob- servational, interview-based study. Chest 2006;130:133-42. [CrossRef]
  • White AJ, Gompertz S, Stockley RA. Chronic obstructive pulmo- nary disease. 6: The aetiology of exacerbations of chronic ob- structive pulmonary disease. Thorax 2003;58:73-80. [CrossRef]
  • Murphy TF, Sethi S. Bacterial infection in chronic obstructive pulmonary disease. Am Rev Respir Dis 1992;146:1067-83. [CrossRef]
  • Monsó E, Ruiz J, Rosell A, et al. Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbat- ed outpatients using the protected specimen brush. Am J Respir Crit Care Med 1995;152:1316-20. [CrossRef]
  • Donaldson GC, Seemungal TA, Bhowmik A, et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002;57:847- 52. [CrossRef]
  • Murphy TF, Brauer AL, Grant BJ, et al. Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response. Am J Respir Crit Care Med 2005;172:195-9. [CrossRef]
  • Sethi S, Evans N, Grant BJ, et al. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002;347:465-71. [CrossRef]
  • Miravitlles M, Espinosa C, Fernández-Laso E, et al. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD. Chest 1999;116:40-6. [CrossRef]
  • Eller J, Ede A, Schaberg T, et al. Infective exacerbations of chron- ic bronchitis: relation between bacteriologic etiology and lung function. Chest 1998;113:1542-8. [CrossRef]
  • Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987;106:196-204. [CrossRef]
  • Murray PR, Washington JA. Microscopic and baceriologic anal- ysis of expectorated sputum. Mayo Clin Proc 1975;50:339-44.
  • Cabello H, Torres A, Celis R, et al. Bacterial colonization of distal airways in healthy subjects and chronic lung disease: a bronchoscopic study. Eur Respir J 1997;10:1137-44. [CrossRef]
  • Wayne P. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. 2004.
  • Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of chronic pulmonary disease, 2011. [Internet]. Available from: http://www.goldcopd.org/Guidelines/guidelines-resources. html.
  • Boixeda R, Rabella N, Sauca G, et al. Microbiological study of patients hospitalized for acute exacerbation of chronic obstruc- tive pulmonary disease (AE-COPD) and the usefulness of ana- lytical and clinical parameters in its identification (VIRAE study). Int J Chron Obstruct Pulmon Dis 2012;7:327-35. [CrossRef]
  • Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerba- tion in chronic obstructive pulmonary disease. N Engl J Med 2010;363:1128-38. [CrossRef]
  • Sapey E, Stockley RA. COPD exacerbations. 2: Aetiology. Tho- rax 2006;61:250-8. [CrossRef]
  • Murphy TF, Brauer AL, Eschberger K, et al. Pseudomonas aeru- ginosa in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2008;177:853-60. [CrossRef]
  • Woodhead M, Blasi F, Ewig S, et al. Guidelines for the man- agement of adult lower respiratory tract infections. Eur Respir J 2005;26:1138-80. [CrossRef]
  • Pauwels RA, Buist AS, Calverley PM, et al. GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/ WHO Global Initiative for Chronic Obstructive Lung Dis- ease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001;163:1256-76. [CrossRef]
  • Garcia-Vidal C, Almagro P, Romaní V, et al. Pseudomonas ae- ruginosa in patients hospitalised for COPD exacerbation: a pro- spective study. Eur Respir J 2009;34:1072-8. [CrossRef]
  • Soler N, Torres A, Ewig S, et al. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med 1998;157:1498-505. [CrossRef]
  • Lin SH, Kuo PH, Hsueh PR, et al. Sputum bacteriology in hos- pitalized patients with acute exacerbation of chronic obstruc- tive pulmonary disease in Taiwan with an emphasis on Kleb- siella pneumoniae and Pseudomonas aeruginosa. Respirology 2007;12:81-7. [CrossRef]
  • Ye F, He LX, Cai BQ, et al. Spectrum and antimicrobial resis- tance of common pathogenic bacteria isolated from patients with acute exacerbation of chronic obstructive pulmonary dis- ease in mainland of China. Chin Med J (Engl) 2013;126:2207- 14.
  • Van de Garde MD, Martinez FO, Melgert BN, et al. Chron- ic exposure to glucocorticoids shapes gene expression and modulates innate and adaptive activation pathways in macro- phages with distinct changes in leukocyte attraction. J Immunol 2014;192:1196-208. [CrossRef]
  • Sethi S, Anzueto A, Miravitlles M, et al. Determinants of bac- teriological outcomes in exacerbations of chronic obstructive pulmonary disease. Infection 2016;44:65-76. [CrossRef]
  • Martinez FJ, Han MK, Flaherty K, et al. Role of infection and an- timicrobial therapy in acute exacerbations of chronic obstruc- tive pulmonary disease. Expert Rev Anti Infect Ther 2006;4:101- 24. [CrossRef]
  • Heineman HS, Chawla JK, Lopton WM. Misinformation from sputum cultures without microscopic examination. J Clin Mi- crobiol 1997;6:518-27.
  • Erkan L, Uzun O, Findik S, et al. Role of bacteria in acute exac- erbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2008;3:463-7. [CrossRef]
  • Ko FW, Ip M, Chan PK, et al. A 1-year prospective study of the infectious etiology in patients hospitalized with acute exacerba- tions of COPD. Chest 2007;131:44-52.[CrossRef]
APA KUWAL A, JOSHI V, Dutt N, SINGH S, AGARWAL K, PUROHIT G (2018). A Prospective Study of Bacteriological Etiology in Hospitalized Acute Exacerbation of COPD Patients: Relationship with Lung Function and Respiratory Failure. , 19 - 27.
Chicago KUWAL Ashok,JOSHI Vinod,Dutt Naveen,SINGH Surjit,AGARWAL Kailash Chand,PUROHIT Gopal A Prospective Study of Bacteriological Etiology in Hospitalized Acute Exacerbation of COPD Patients: Relationship with Lung Function and Respiratory Failure. (2018): 19 - 27.
MLA KUWAL Ashok,JOSHI Vinod,Dutt Naveen,SINGH Surjit,AGARWAL Kailash Chand,PUROHIT Gopal A Prospective Study of Bacteriological Etiology in Hospitalized Acute Exacerbation of COPD Patients: Relationship with Lung Function and Respiratory Failure. , 2018, ss.19 - 27.
AMA KUWAL A,JOSHI V,Dutt N,SINGH S,AGARWAL K,PUROHIT G A Prospective Study of Bacteriological Etiology in Hospitalized Acute Exacerbation of COPD Patients: Relationship with Lung Function and Respiratory Failure. . 2018; 19 - 27.
Vancouver KUWAL A,JOSHI V,Dutt N,SINGH S,AGARWAL K,PUROHIT G A Prospective Study of Bacteriological Etiology in Hospitalized Acute Exacerbation of COPD Patients: Relationship with Lung Function and Respiratory Failure. . 2018; 19 - 27.
IEEE KUWAL A,JOSHI V,Dutt N,SINGH S,AGARWAL K,PUROHIT G "A Prospective Study of Bacteriological Etiology in Hospitalized Acute Exacerbation of COPD Patients: Relationship with Lung Function and Respiratory Failure." , ss.19 - 27, 2018.
ISNAD KUWAL, Ashok vd. "A Prospective Study of Bacteriological Etiology in Hospitalized Acute Exacerbation of COPD Patients: Relationship with Lung Function and Respiratory Failure". (2018), 19-27.
APA KUWAL A, JOSHI V, Dutt N, SINGH S, AGARWAL K, PUROHIT G (2018). A Prospective Study of Bacteriological Etiology in Hospitalized Acute Exacerbation of COPD Patients: Relationship with Lung Function and Respiratory Failure. Turkish Thoracic Journal, 19(1), 19 - 27.
Chicago KUWAL Ashok,JOSHI Vinod,Dutt Naveen,SINGH Surjit,AGARWAL Kailash Chand,PUROHIT Gopal A Prospective Study of Bacteriological Etiology in Hospitalized Acute Exacerbation of COPD Patients: Relationship with Lung Function and Respiratory Failure. Turkish Thoracic Journal 19, no.1 (2018): 19 - 27.
MLA KUWAL Ashok,JOSHI Vinod,Dutt Naveen,SINGH Surjit,AGARWAL Kailash Chand,PUROHIT Gopal A Prospective Study of Bacteriological Etiology in Hospitalized Acute Exacerbation of COPD Patients: Relationship with Lung Function and Respiratory Failure. Turkish Thoracic Journal, vol.19, no.1, 2018, ss.19 - 27.
AMA KUWAL A,JOSHI V,Dutt N,SINGH S,AGARWAL K,PUROHIT G A Prospective Study of Bacteriological Etiology in Hospitalized Acute Exacerbation of COPD Patients: Relationship with Lung Function and Respiratory Failure. Turkish Thoracic Journal. 2018; 19(1): 19 - 27.
Vancouver KUWAL A,JOSHI V,Dutt N,SINGH S,AGARWAL K,PUROHIT G A Prospective Study of Bacteriological Etiology in Hospitalized Acute Exacerbation of COPD Patients: Relationship with Lung Function and Respiratory Failure. Turkish Thoracic Journal. 2018; 19(1): 19 - 27.
IEEE KUWAL A,JOSHI V,Dutt N,SINGH S,AGARWAL K,PUROHIT G "A Prospective Study of Bacteriological Etiology in Hospitalized Acute Exacerbation of COPD Patients: Relationship with Lung Function and Respiratory Failure." Turkish Thoracic Journal, 19, ss.19 - 27, 2018.
ISNAD KUWAL, Ashok vd. "A Prospective Study of Bacteriological Etiology in Hospitalized Acute Exacerbation of COPD Patients: Relationship with Lung Function and Respiratory Failure". Turkish Thoracic Journal 19/1 (2018), 19-27.